Abstract
BackgroundTime to treatment failure is the primary endpoint in the VISUAL-1 clinical trial (NCT01138657) of patients with non-infectious intermediate-, posterior- and pan-uveitis (NIIPPU); however, the relationship between the treatment failure...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have